| 211 |
Impact of Comorbidities on Outcome of Diffuse Large B Cell Lymphoma (DLBCL) |
2017 |
| 212 |
Impact of Comorbidities on Outcome of Diffuse Large B Cell Lymphoma (DLBCL) |
2017 |
| 213 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 214 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 215 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 216 |
Nosocomial hepatitis C infection among hemodialysis patients:
a single center study in Assuit University Hospital |
2017 |
| 217 |
Obesity risk prediction among women of Upper Egypt: The impact of serum
vaspin and vaspin rs2236242 gene polymorphism
|
2017 |
| 218 |
Obesity risk prediction among women of Upper Egypt: The impact of serum
vaspin and vaspin rs2236242 gene polymorphism
|
2017 |
| 219 |
Prognostic Impact of Hepatitis C Virus Infection on Treatment Related Hepatic Toxicity and Survival of Non-Hodgkin Lymphoma Patients |
2017 |
| 220 |
Prognostic Impact of Hepatitis C Virus Infection on Treatment Related Hepatic Toxicity and Survival of Non-Hodgkin Lymphoma Patients |
2017 |
هل لديك سؤال ؟
